Haralabos Zacharatos, DO., is an experienced, fellowship-trained neurologist specializing in neurovascular and endovascular neurosurgery. With over 20 years of clinical experience, he is dedicated to improving outcomes for patients with a wide range of neurological conditions, particularly those affected by stroke, meningitis, and arteriovenous malformations (AVMs). As a board-certified neurologist at the Hackensack Meridian Neuroscience Institute at JFK University Medical Center in Edison, New Jersey, he plays a key role in advancing stroke treatment and patient care in the region.
Dr. Zacharatos has developed particular expertise in the prevention, diagnosis, and management of ischemic and hemorrhagic strokes, as well as transient ischemic attack (TIAs or mini- strokes), with a focus on both acute intervention and long-term recovery. His extensive training includes fellowships in endovascular surgical neuroradiology and vascular neurology at the University of Minnesota Medical School, where he honed his skills in the latest diagnostic and therapeutic techniques for stroke and cerebrovascular disorders.
Throughout his career, Dr. Zacharatos has made significant contributions to the field of stroke research. He has co-published several journal articles and book chapters on topics ranging from stroke pathophysiology to advanced treatment strategies. His research achievements have earned him prestigious awards, including the Mary Bizal Peterson Research Award and The John R. Gates Award.
In addition to his clinical and academic work, Dr. Zacharatos was actively involved in the early response to the COVID-19 pandemic, researching novel therapies and disease patterns. He participated in the Mayo Clinic’s Expanded Access Program for convalescent plasma, exploring potential treatments for severe COVID-19 patients.
Dr. Zacharatos remains deeply committed to advancing the field of neurology, continually refining his expertise to provide the highest level of care for patients. His leadership in stroke management and dedication to patient outcomes make him a trusted resource in the field.